Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

CareMax, Inc. CMAX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.60
+516.8%

CareMax, Inc. (CMAX) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.42. It has a SharesGrow Score of 36/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Analyst consensus target is CMAX = $3 (+516.8% upside).

Financials: revenue is $751M, +106.1%/yr average growth. Net income is $683M (loss), growing at -795.5%/yr. Net profit margin is -91% (negative). Gross margin is 1.9% (-17.4 pp trend).

Balance sheet: total debt is $492M against $61M equity (Debt-to-Equity (D/E) ratio 8.01, leveraged). Current ratio is 0.42 (tight liquidity). Debt-to-assets is 78.9%. Total assets: $623M.

Analyst outlook: 2 / 5 analysts rate CMAX as buy (40%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 0/100 (Fail), Moat 8/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).

$2.60
▲ 516.84% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for CareMax, Inc., the average price target is $2.60, with a high forecast of $3.00, and a low forecast of $2.20.
Highest Price Target
$3.00
Average Price Target
$2.60
Lowest Price Target
$2.20

CMAX SharesGrow Score Overview

42/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 8/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CMAX

✓
VALUE Pass
100/100
CMAX trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $3, implying +611.7% from the current price $0. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
CMAX: +106.1%/yr revenue is, -795.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
CMAX: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
8/100
CMAX: Gross margin is 1.9% (-17.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 8/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 2 / 5 analysts rate CMAX as buy (40%). Analyst consensus target is $3 (+611.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
CMAX: Net profit margin is -91%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.4215-0.52
Volume772.04K
Avg Volume (30D)1.22M
Market Cap$1.61M
Beta (1Y)0.68
Share Statistics
EPS (TTM)-183.30
Shares Outstanding$3.73M
IPO Date2020-09-21
Employees1,450
CEOCarlos A. de Solo
Financial Highlights & Ratios
Revenue (TTM)$751.1M
Gross Profit$13.9M
EBITDA$-590.46M
Net Income$-683.35M
Operating Income$-656.15M
Total Cash$65.53M
Total Debt$491.93M
Net Debt$426.41M
Total Assets$623.3M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
1Y Price Target$2.60
Target High$3.00
Target Low$2.20
Upside+516.8%
Rating ConsensusHold
Analysts Covering5
Buy 40% Hold 60% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS14171W2026

Price Chart

Track all markets on TradingView
CMAX
CareMax, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Healthcare Information Services
0.42 52WK RANGE 0.52

People Also View

HQY
HQY
HealthEquity, Inc.
$81.36
+1.81%
 RCM
RCM
R1 RCM Inc.
$14.31
+0.00%
 PRVA
PRVA
Privia Health Group, Inc.
$23.12
+0.48%
 AGTI
AGTI
Agiliti, Inc.
$10.05
-0.50%
 CERT
CERT
Certara, Inc.
$5.82
+0.52%
 HSTM
HSTM
HealthStream, Inc.
$20.34
-0.15%
 NRC
NRC
National Research Corporation
$17.04
+1.34%
 TRHC
TRHC
Tabula Rasa HealthCare, Inc.
$10.50
+0.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message